Almost all women with breast cancer have dermatofibromas.
Five women with breast cancer had their dermatofibromas excised and tested for arsenic. A total of 56 women with breast cancer and 56 women without breast cancer were examined for the presence of dermatofibromas.
The Cause of Breast Cancer
Dermatofibromas were found to have a lethal amount of arsenic. Either the dermatofibroma was caused by arsenic or became a reservoir to trap arsenic. Women with breast cancer and multiple dermatofibromas (n = 38) had a 100% chance of getting the disease. Women with 1 dermatofibroma (n = 11) had a 60% chance of getting the disease. Women with no dermatofibromas (n = 7) had only a 12% chance of getting the disease. In the group without breast cancer, 47 of 56 patients had no dermatofibromas and none had multiple dermatofibromas. Nine patients had 1 dermatofibroma but, as shown by the Figure, had protection by not following every step (probability).
Dermatofibromas are caused by arsenic and set off a cascade of events leading to breast cancer. Screening women in their 20s, 30s, and 40s for dermatofibromas and removing them should eradicate at least 80% to 90% of breast cancer cases.
Considering NCCN Guidelines to Determine Maintenance Therapy Multiple Myeloma
February 15th 2025During the 66th American Society of Hematology Annual Meeting and Exposition, experts in multiple myeloma gathered to discuss the impact of maintenance therapy and minimal residual disease (MRD) in patients with newly diagnosed transplant-eligible or -ineligible multiple myeloma.